Email this article 
Post a Comment Modern approach to combination therapy in patients with pelvic inflammatory diseases
- Authors: Khasanova V.V.1,2, Kukarskaya I.I.1,2, Shevlyukova T.P.1, Kukarskaya E.Y.1
-
Affiliations:
- Tyumen State Medical University
- Perinatal Center
- Issue: Vol 38, No 2 (2021)
- Pages: 45-55
- Section: Original studies
- URL: https://journals.rcsi.science/PMJ/article/view/71381
- DOI: https://doi.org/10.17816/pmj38245-55
- ID: 71381
Cite item
Full Text
Abstract
Objective. The aim of the study was to compare the efficiency of complex therapy of pelvic inflammatory diseases (PID) in patients using the drug Longidaza® and the effectiveness of therapy without the use of this drug.
Materials and methods. 150 patients of reproductive age with PID. All women underwent basic therapy. The complex treatment of group 1 included the additional drug Longidaza® in vaginal suppositories 3000 IU with the general course of 20 injections once every three days. The patients were observed for 60 days. The effectiveness of therapy was determined by the dynamics of diagnostic criteria (clinical and laboratory).
Results. During the follow-up period, among patients receiving complex therapy with Longidaza® relief of pain syndrome in the lower abdomen was observed much faster, and only 14 (18,5 %) women of group 1 continued to fill it after 2 months of treatment, where as in group 2 – 60 (81,1 %) patients (p < 0,001). Reduction of pain in palpation and cervical traction in patients of the main group was recorded in all (100 %) patients, while in the group of basic therapy this symptom continued to be observed in 23 % of women (p < 0.001). The dynamics of decrease in the share of patients with increased uterine size in group 1 was 14.9 % and in group 2 – only 8.4 % (p < 0.001). In the experimental group, during the 2-month follow-up period, there was observed an increase in the number of patients with a normal number of leukocytes in the vaginal smear by 13 %, while in the second group this parameter increased by only 3 % to the initial value.
Conclusions. The results of the research allow indicating the efficiency of treatment of PID when using the drug Longidaza®.
Full Text
##article.viewOnOriginalSite##About the authors
V. V. Khasanova
Tyumen State Medical University; Perinatal Center
Email: tata21.01@mail.ru
Candidate of Medical Sciences, Associate Professor, Department of Obstetrics, Gynecology and Resuscitation with Course of Clinical Laboratory Diagnostics of Institute of Continuing Professional Development, Head of Surgical and Obstetric Unit
Russian Federation, TyumenI. I. Kukarskaya
Tyumen State Medical University; Perinatal Center
Email: tata21.01@mail.ru
MD, PhD, Chief Specialist in Obstetrics and Gynecology of Department of Healthcare of Tyumen Region, Professor of Department of Obstetrics, Gynecology and Resuscitation with Course of Clinical Laboratory Diagnostics of Institute of Continuing Professional Development, chief medical officer of Perinatal Center
Russian Federation, TyumenT. P. Shevlyukova
Tyumen State Medical University
Author for correspondence.
Email: tata21.01@mail.ru
MD, PhD, Professor, Department of Obstetrics and Gynecology
Russian Federation, TyumenE. Yu. Kukarskaya
Tyumen State Medical University
Email: tata21.01@mail.ru
resident, Department of Obstetrics and Gynecology
Russian Federation, TyumenReferences
- Sexually Transmitted Diseases Treatment Guidelines, СDC. MMWR. June 5, 2015; 64 (3): 137.
- Kobaidze E.G., Padrul M.M. Impaired function of the endometrium in chronic inflammation of the uterus. Permskij medicinskij zhurnal 2014; 31 (5): 92–101 (in Russian).
- Kubanova A.A, Lesnaya I.N., Kubanov A.A., Melekhina L.E., Kaspirovich M.A. Analysis of the epidemiological situation and the dynamics of the incidence of sexually transmitted infections and dermatoses in the Russian Federation. Vestnik dermatologii i venerologii 2010; 5: 4–21 (in Russian).
- Sweet R.L. Pelvic Inflammatory Disease: Current Concepts of Diagnosis and Management. Curr Infect Dis Rep 2012; 14: 194–203.
- Olina A.A., Sadykova G.K., Meteleva T.A. Analysis of demographic processes in the Perm Region. Permskij medicinskij zhurnal 2018; 35 (3): 67–73 (in Russian).
- Prilepskaya V.N., Bebneva T.N. The effectiveness of the immunomodulator Galavit in the treatment of inflammatory diseases of the pelvic organs. Russkij medicinskij zhurnal 2013; 1: 31–38 (in Russian).
- Serov V.N., Tverdikova M.A., Veresova A.A. Immunomodulators in the complex therapy of inflammatory diseases of the pelvic organs. Russkij medicinskij zhurnal 2011; 20: 1218–1223 (in Russian).
- Kurbanova D.F. Inflammatory diseases of the uterus appendages. M.: Medicine 2007; 160 (in Russian).
- Baymuradova S. M. Pathogenesis, principles of diagnosis, prevention and therapy of fetal loss syndrome caused by acquired and genetic defects of hemostasis: diss. … doctor of Medical Sciences. Moscow 2007; 396 (in Russian).
- Tirskaya Y.I., Rudakova E.B. Schakina I.A., Tsygankova O.Y. The role of cervicitis in obstetric and gynecological pathology. Lechashhij vrach 2009; 10: 63–66 (in Russian).
- Tatarchuk T.F., Efimenko O.A. The role of hyperprolactinemia in the formation and realization of reproductive function. Mezhdunarodnyj jendokrinologicheskij zhurnal 2010; 3 (27) (in Russian).
- Barinov S.V., Pisklakov A.V., Shakhoval V.S., Pavlenko N.I. Chronic pelvic pain syndrome in girls. Medicinskaja nauka i obrazovanie Urala 2012; 13 (71): 36–39 (in Russian).
- Krasnopolsky V.I., Buyanova S.N., Shchukina N.A. Purulent inflammatory diseases of the uterine appendages. Moscow: MEDpress-Inform 2006; 296 (in Russian).
- Bugg C.W., Taira T., Zaurova M. Pelvic inflammatory disease: diagnosis and treatment in the emergency department [digest]. Emerg Med Pract 2016; 1 (12, Suppl. Points & Pearls): 1–2 (in Russian).
- Olina A.A. Epidemiological and microbiological aspects of non-specific infectious diseases of the vagina. Ural'skij medicinskij zhurnal 2008; 8 (48): 160–163 (in Russian).
- Padrul M.M., Olina A.A., Pirozhnikova N.M., Padrul V.M. Immunotherapy of sexually transmitted infections. Training manual. Perm 2006; 81 (in Russian).
- Instructions for the medical use of the drug Longidase vaginal and rectal suppositories. LSR-002940/07. 2016 (in Russian).
- Nekrasov A.V., Ivanova A.S. Longidase – a modern approach in the treatment of diseases accompanied by connective tissue hyperplasia. Signatura 2006; 1: 43–52 (in Russian).
Supplementary files
